Human Liver Model Market Report 2026

Human Liver Model Market Overview

• Human Liver Model market size has reached to $2.62 billion in 2025 • Expected to grow to $5.02 billion in 2030 at a compound annual growth rate (CAGR) of 14% • Growth Driver: Increasing Clinical Trials Is Anticipated To Fuel The Human Liver Model Market • Market Trend: Advanced System To Enhance Adoption Of Predictive Human Liver Models • North America was the largest region in 2025.

What Is Covered Under Human Liver Model Market?

The human liver model refers to the model of dual-lobed liver of humans that is primarily in charge of filtering blood from the digestive tract. It is used to show and evaluate the toxic effects of drug candidates on the liver. The main human liver model product types are liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. Liver organoids refer to 3D structures that are generated from stem cells and self-organize through mechanisms similar to those in vivo. The various applications are educational, drug discovery, and others and are used in research institutes, pharmaceutical companies, and others.

What Is The Human Liver Model Market Growth Forecast?

The human liver model market size is expected to see rapid growth in the next few years. It will grow to $5.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for precision toxicology models, expansion of organ-on-chip technologies, growing regulatory focus on reducing animal testing, rising investment in advanced in vitro research tools, increasing use of human-relevant models in early drug development. Major trends in the forecast period include increasing adoption of advanced in vitro liver models for toxicity testing, growing use of liver organoids in drug discovery pipelines, rising preference for human-relevant models over animal testing, expansion of liver-on-a-chip applications in preclinical research, increasing demand for predictive hepatotoxicity assessment tools.

Global Human Liver Model Market Segmentation

1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, 3D Bioprinting 2) By Application: Educational, Drug Discovery, Other Applications 3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users Subsegments: 1) By Liver Organoids: Primary Liver Organoids, Induced Pluripotent Stem Cell (iPSC)-Derived Organoids 2) By Liver-On-A-Chip: Microfluidic Liver Chips, Multi-Organ Chip Systems 3) By 2D Models: Liver Cell Cultures, Liver Cell Lines 4) By 3D Bioprinting: Bioprinted Liver Tissues, Hybrid Bioprinted Models

What Is The Driver Of The Human Liver Model Market?

The increasing clinical trials are expected to propel the growth of the human liver model market going forward. Clinical trials are research studies conducted to evaluate the safety and efficacy of medical interventions, treatments, or drugs in humans. Human liver models are utilized in clinical trials to simulate and study drug metabolism and hepatotoxicity for pharmaceutical development. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the total number of clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023. Therefore, increasing clinical trials is driving the human liver model industry.

Key Players In The Global Human Liver Model Market

Major companies operating in the human liver model market are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

Global Human Liver Model Market Trends and Insights

Major companies in the human liver model market are focused on developing advanced systems, such as single-organ higher throughput (HT) systems, to enhance the adoption of predictive human liver models and to gain a competitive edge in the market. A single-organ higher throughput (HT) system is a technology designed for scalable and cost-effective drug discovery, overcoming obstacles in the adoption of predictive human liver models. For instance, in February 2023, CN Bio, a UK-based organ-on-a-chip company, launched PhysioMimix with Liver-48 plate, a single-organ higher throughput (HT) system designed to address obstacles hindering the use of predictive human liver models in drug discovery. The technology offers a scalable and cost-effective solution, allowing researchers to conduct larger-scale comparative studies on drug disposition, efficacy, or safety. The Liver-48 plate is a multi-chip consumable that miniaturizes the company's human liver model for applications including predicting drug-induced liver injury and assessing drug metabolism.

What Are Latest Mergers And Acquisitions In The Human Liver Model Market?

In April 2023, AnaBios Corporation, a biotechnology research company, acquired Cell Systems for an undisclosed amount. This acquisition aims to enhance its capabilities in drug discovery and development by integrating Cell Systems' advanced cell-based technologies. The acquisition strengthens AnaBios' portfolio in the areas of human-relevant models, enabling more accurate predictions of drug efficacy and safety. Cell Systems is US-based biotechnology research.

Regional Outlook

North America was the largest region in the human liver model market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Liver Model Market?

The human liver model market consists of sales of 3B scientific liver and prime baker fiber liver model. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Liver Model Market Report 2026?

The human liver model market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human liver model industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.